Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Cash from Financing Activities (2020 - 2026)

Edgewise Therapeutics has reported Cash from Financing Activities over the past 7 years, most recently at $12.2 million for Q1 2026.

  • Quarterly results put Cash from Financing Activities at $12.2 million for Q1 2026, up 447.59% from a year ago — trailing twelve months through Mar 2026 was $206.0 million (up 1880.56% YoY), and the annual figure for FY2025 was $196.1 million, down 21.33%.
  • Cash from Financing Activities reached $12.2 million in Q1 2026 per EWTX's latest filing, up from $4.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $241.1 million in Q1 2024 and bottomed at -$303000.0 in Q4 2022.
  • Median Cash from Financing Activities over the past 5 years was $2.2 million (2025), compared with a mean of $37.7 million.
  • The largest annual shift saw Cash from Financing Activities plummeted 203.41% in 2022 before it skyrocketed 1147866.67% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$303000.0 in 2022, then soared by 17587.46% to $53.0 million in 2023, then tumbled by 94.54% to $2.9 million in 2024, then soared by 37.31% to $4.0 million in 2025, then soared by 206.24% to $12.2 million in 2026.
  • Business Quant data shows Cash from Financing Activities for EWTX at $12.2 million in Q1 2026, $4.0 million in Q4 2025, and $1.7 million in Q3 2025.